DOMPE
Elisabetta Mauri has extensive experience in intellectual property and research and development strategy. Elisabetta is currently the Head of R&D Strategy and IP at Dompé since March 2023. Prior to that, they were the Head of Intellectual Property at Dompé from February 2019 to March 2023. Elisabetta also served as a Senior Partner-Italian and European Patent Attorney-Pharmaceuticals Chemistry Biotechnology at PGA SpA from November 2011 to February 2019. Elisabetta Mauri has worked in various roles related to patent attorney and research associate in different companies and institutions including Dompé SpA, Dragotti e Associati, Notarbartolo e Gervasi, Boult Wade Tennant, Department of Experimental Pathology at Guy's Hospital, Centro di Farmacologia Molecolare; Istituto Scienze farmacologiche, and Centre for Reproductive Sciences Columbia University.
Elisabetta Mauri studied Chimica e Tecnologia Farmaceutica at Università degli Studi di Milano and graduated in 1996. In 1999 to 2000, they attended Queen Mary University of London for a Certificate in Intellectual Property Law. Elisabetta also attended Liceo Berchet from 1984 to 1989.
DOMPE
2 followers
DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personalhygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory.Founded in 1940, Dompe is headquartered in Milan, Italy.